Amit, I., Winter, D. R. & Jung, S. The role of the local environment and epigenetics in shaping macrophage identity and their effect on tissue homeostasis. Nat. Immunol. 17, 18–25 (2016).
Aurora, A. B. et al. Macrophages are required for neonatal heart regeneration. J. Clin. Invest. 124, 1382–1392 (2014).
Godwin, J. W., Pinto, A. R. & Rosenthal, N. A. Macrophages are required for adult salamander limb regeneration. Proc. Natl. Acad. Sci. USA 110, 9415–9420 (2013).
Kolter, J. et al. A subset of skin macrophages contributes to the surveillance and regeneration of local nerves. Immunity 50, 1482–1497.e1487 (2019).
Roberts, A. W. et al. Tissue-resident macrophages are locally programmed for silent clearance of apoptotic cells. Immunity 47, 913–927.e916 (2017).
Knipper, J. A. et al. Interleukin-4 receptor alpha signaling in myeloid cells controls collagen fibril assembly in skin repair. Immunity 43, 803–816 (2015).
Zhang, N. et al. Expression of factor V by resident macrophages boosts host defense in the peritoneal cavity. J. Exp. Med. 216, 1291–1300 (2019).
Deniset, J. F. et al. Gata6(+) pericardial cavity macrophages relocate to the injured heart and prevent cardiac fibrosis. Immunity 51, 131–140.e135 (2019).
Nicolas-Avila, J. A. et al. A network of macrophages supports mitochondrial homeostasis in the heart. Cell 183, 94–109.e123 (2020).
Hulsmans, M. et al. Macrophages facilitate electrical conduction in the heart. Cell 169, 510–522.e520 (2017).
Culemann, S. et al. Locally renewing resident synovial macrophages provide a protective barrier for the joint. Nature 572, 670–675 (2019).
Nguyen, P. T. et al. Microglial remodeling of the extracellular matrix promotes synapse plasticity. Cell 182, 388–403.e315 (2020).
Wang, C. et al. Microglia mediate forgetting via complement-dependent synaptic elimination. Science 367, 688–694 (2020).
Badimon, A. et al. Negative feedback control of neuronal activity by microglia. Nature 586, 417–423 (2020).
Willis, E. F. et al. Repopulating microglia promote brain repair in an IL-6-dependent manner. Cell 180, 833–846.e816 (2020).
Boutens, L. & Stienstra, R. Adipose tissue macrophages: going off track during obesity. Diabetologia 59, 879–894 (2016).
Bu, L., Gao, M., Qu, S. & Liu, D. Intraperitoneal injection of clodronate liposomes eliminates visceral adipose macrophages and blocks high-fat diet-induced weight gain and development of insulin resistance. AAPS J. 15, 1001–1011 (2013).
Burlinson, E. L., Drakes, M. L. & Wood, P. J. Differential patterns of production of granulocyte macrophage colony stimulating factor, IL-2, IL-3 and IL-4 by cultured islets of Langerhans from non-obese diabetic and non-diabetic strains of mice. Int. Immunol. 7, 79–87 (1995).
Camell, C. D. et al. Inflammasome-driven catecholamine catabolism in macrophages blunts lipolysis during ageing. Nature 550, 119–123 (2017).
Chawla, A., Nguyen, K. D. & Goh, Y. P. Macrophage-mediated inflammation in metabolic disease. Nat. Rev. Immunol. 11, 738–749 (2011).
Chow, F., Ozols, E., Nikolic-Paterson, D. J., Atkins, R. C. & Tesch, G. H. Macrophages in mouse type 2 diabetic nephropathy: correlation with diabetic state and progressive renal injury. Kidney Int. 65, 116–128 (2004).
Fan, R. et al. Loss of the co-repressor GPS2 sensitizes macrophage activation upon metabolic stress induced by obesity and type 2 diabetes. Nat. Med. 22, 780–791 (2016).
Feng, B. et al. Clodronate liposomes improve metabolic profile and reduce visceral adipose macrophage content in diet-induced obese mice. PLoS One 6, e24358 (2011).
Kang, K. et al. Adipocyte-derived Th2 cytokines and myeloid PPARdelta regulate macrophage polarization and insulin sensitivity. Cell Metab. 7, 485–495 (2008).
Kanter, J. E. et al. Diabetes promotes an inflammatory macrophage phenotype and atherosclerosis through acyl-CoA synthetase 1. Proc. Natl. Acad. Sci. USA 109, E715–E724 (2012).
Lee, B. C. et al. Adipose natural killer cells regulate adipose tissue macrophages to promote insulin resistance in obesity. Cell Metab. 23, 685–698 (2016).
Liao, X. et al. Kruppel-like factor 4 regulates macrophage polarization. J. Clin. Invest. 121, 2736–2749 (2011).
Lumeng, C. N., Bodzin, J. L. & Saltiel, A. R. Obesity induces a phenotypic switch in adipose tissue macrophage polarization. J. Clin. Invest. 117, 175–184 (2007).
McNelis, J. C. & Olefsky, J. M. Macrophages, immunity, and metabolic disease. Immunity 41, 36–48 (2014).
Nagareddy, P. R. et al. Adipose tissue macrophages promote myelopoiesis and monocytosis in obesity. Cell Metab. 19, 821–835 (2014).
Odegaard, J. I. et al. Macrophage-specific PPARgamma controls alternative activation and improves insulin resistance. Nature 447, 1116–1120 (2007).
Okabe, Y. & Medzhitov, R. Tissue biology perspective on macrophages. Nat. Immunol. 17, 9–17 (2016).
Parathath, S. et al. Diabetes adversely affects macrophages during atherosclerotic plaque regression in mice. Diabetes 60, 1759–1769 (2011).
Ramkhelawon, B. et al. Netrin-1 promotes adipose tissue macrophage retention and insulin resistance in obesity. Nat. Med. 20, 377–384 (2014).
Saeed, S. et al. Epigenetic programming of monocyte-to-macrophage differentiation and trained innate immunity. Science 345, 1251086 (2014).
Satoh, T. et al. Critical role of Trib1 in differentiation of tissue-resident M2-like macrophages. Nature 495, 524–528 (2013).
Schilling, J. D., Machkovech, H. M., Kim, A. H., Schwendener, R. & Schaffer, J. E. Macrophages modulate cardiac function in lipotoxic cardiomyopathy. Am. J. Physiol. Heart Circ. Physiol. 303, H1366–H1373 (2012).
Schmidt, A. M. & Moore, K. J. The Semaphorin 3E/PlexinD1 axis regulates macrophage inflammation in obesity. Cell Metab. 18, 461–462 (2013).
Weisberg, S. P. et al. Obesity is associated with macrophage accumulation in adipose tissue. J. Clin. Investig. 112, 1796–1808 (2003).
Wu, D. et al. Eosinophils sustain adipose alternatively activated macrophages associated with glucose homeostasis. Science 332, 243–247 (2011).
Wynn, T. A., Chawla, A. & Pollard, J. W. Macrophage biology in development, homeostasis and disease. Nature 496, 445–455 (2013).
Zheng, C. et al. CD11b regulates obesity-induced insulin resistance via limiting alternative activation and proliferation of adipose tissue macrophages. Proc. Natl. Acad. Sci. USA 112, E7239–E7248 (2015).
Jaitin, D. A. et al. Lipid-associated macrophages control metabolic homeostasis in a trem2-dependent manner. Cell 178, 686–698.e614 (2019).
Vasamsetti, S. B. et al. Apoptosis of hematopoietic progenitor-derived adipose tissue-resident macrophages contributes to insulin resistance after myocardial infarction. Sci. Transl. Med. 12, eaaw0638 (2020).
Weisberg, S. P. et al. CCR2 modulates inflammatory and metabolic effects of high-fat feeding. J. Clin. Invest 116, 115–124 (2006).
Mu, X., Li, Y. & Fan, G. C. Tissue-resident macrophages in the control of infection and resolution of inflammation. Shock 55, 14–23 (2021).
Chen, Q. et al. Resident macrophages restrain pathological adipose tissue remodeling and protect vascular integrity in obese mice. EMBO Rep. 22, e52835 (2021).
Silva, H. M. et al. Vasculature-associated fat macrophages readily adapt to inflammatory and metabolic challenges. J. Exp. Med. 216, 786–806 (2019).
Schroder, W. A., Major, L. & Suhrbier, A. The role of SerpinB2 in immunity. Crit. Rev. Immunol. 31, 15–30 (2011).
Flevaris, P. & Vaughan, D. The role of plasminogen activator inhibitor type-1 in fibrosis. Semin. Thromb. Hemost. 43, 169–177 (2017).
Alessi, M. C. et al. Production of plasminogen activator inhibitor 1 by human adipose tissue: possible link between visceral fat accumulation and vascular disease. Diabetes 46, 860–867 (1997).
Loskutoff, D. J., Fujisawa, K. & Samad, F. The fat mouse. A powerful genetic model to study hemostatic gene expression in obesity/NIDDM. Ann. NY Acad. Sci. 902, 272–281 (2000).
Lee, S. M. et al. TM5441, a plasminogen activator inhibitor-1 inhibitor, protects against high fat diet-induced non-alcoholic fatty liver disease. Oncotarget 8, 89746–89760 (2017).
Ma, L. J. et al. Prevention of obesity and insulin resistance in mice lacking plasminogen activator inhibitor 1. Diabetes 53, 336–346 (2004).
Flevaris, P. et al. Plasminogen activator inhibitor type i controls cardiomyocyte transforming growth factor-beta and cardiac fibrosis. Circulation 136, 664–679 (2017).
Eitzman, D. T. et al. Bleomycin-induced pulmonary fibrosis in transgenic mice that either lack or overexpress the murine plasminogen activator inhibitor-1 gene. J. Clin. Invest. 97, 232–237 (1996).
Yao, L. et al. Fibroblast-specific plasminogen activator inhibitor-1 depletion ameliorates renal interstitial fibrosis after unilateral ureteral obstruction. Nephrol. Dial. Transpl. 34, 2042–2050 (2019).
Song, C., Burgess, S., Eicher, J. D., O’Donnell, C. J. & Johnson, A. D. Causal effect of plasminogen activator inhibitor type 1 on coronary heart disease. J. Am. Heart Assoc. 6, e004918 (2017).
Khoukaz, H. B. et al. Drug targeting of plasminogen activator inhibitor-1 inhibits metabolic dysfunction and atherosclerosis in a murine model of metabolic syndrome. Arterioscler. Thromb. Vasc. Biol. 40, 1479–1490 (2020).
Kubala, M. H. et al. Plasminogen activator inhibitor-1 promotes the recruitment and polarization of macrophages in cancer. Cell Rep. 25, 2177–2191.e2177 (2018).
Nakatsuka, E. et al. Plasminogen activator inhibitor-1 is an independent prognostic factor of ovarian cancer and IMD-4482, a novel plasminogen activator inhibitor-1 inhibitor, inhibits ovarian cancer peritoneal dissemination. Oncotarget 8, 89887–89902 (2017).
Ballatori, N. et al. Glutathione dysregulation and the etiology and progression of human diseases. Biol. Chem. 390, 191–214 (2009).
Kumar, P. et al. Supplementing glycine and N-acetylcysteine (GlyNAC) in older adults improves glutathione deficiency, oxidative stress, mitochondrial dysfunction, inflammation, physical function, and aging hallmarks: a randomized clinical trial. J. Gerontol. A Biol. Sci. Med. Sci. 78, 75–89 (2023).
Vasamsetti, S. B. et al. Resveratrol attenuates monocyte-to-macrophage differentiation and associated inflammation via modulation of intracellular GSH homeostasis: relevance in atherosclerosis. Free Radic. Biol. Med. 96, 392–405 (2016).
Busu, C., Atanasiu, V., Caldito, G. & Aw, T. Y. Influence of GSH synthesis inhibition on temporal distribution of NAD+/NADH during vascular endothelial cells proliferation. J. Med. Life 7, 611–618 (2014).
Teskey, G. et al. Glutathione as a marker for human disease. Adv. Clin. Chem. 87, 141–159 (2018).
Kumar, P. et al. Glycine and N-acetylcysteine (GlyNAC) supplementation in older adults improves glutathione deficiency, oxidative stress, mitochondrial dysfunction, inflammation, insulin resistance, endothelial dysfunction, genotoxicity, muscle strength, and cognition: Results of a pilot clinical trial. Clin. Transl. Med. 11, e372 (2021).
Espinosa-Diez, C. et al. Role of glutathione biosynthesis in endothelial dysfunction and fibrosis. Redox Biol. 14, 88–99 (2018).
Sheeran, F. L. & Pepe, S. Posttranslational modifications and dysfunction of mitochondrial enzymes in human heart failure. Am. J. Physiol. Endocrinol. Metab. 311, E449–E460 (2016).
Tan, M. et al. Glutathione system enhancement for cardiac protection: pharmacological options against oxidative stress and ferroptosis. Cell Death Dis. 14, 131 (2023).
Jang, S. et al. Elucidating the contribution of mitochondrial glutathione to ferroptosis in cardiomyocytes. Redox Biol. 45, 102021 (2021).
Joffre, J. et al. Genetic and pharmacological inhibition of TREM-1 limits the development of experimental atherosclerosis. J. Am. Coll. Cardiol. 68, 2776–2793 (2016).
Zysset, D. et al. TREM-1 links dyslipidemia to inflammation and lipid deposition in atherosclerosis. Nat. Commun. 7, 13151 (2016).
Shaw, T. N. et al. Tissue-resident macrophages in the intestine are long lived and defined by Tim-4 and CD4 expression. J. Exp. Med. 215, 1507–1518 (2018).
Saade, M., Araujo de Souza, G., Scavone, C. & Kinoshita, P. F. The role of GPNMB in inflammation. Front. Immunol. 12, 674739 (2021).
Missiou, A. et al. Tumor necrosis factor receptor-associated factor 1 (TRAF1) deficiency attenuates atherosclerosis in mice by impairing monocyte recruitment to the vessel wall. Circulation 121, 2033–2044 (2010).
Padilla, J. et al. Identification of genes whose expression is altered by obesity throughout the arterial tree. Physiol. Genomics 46, 821–832 (2014).
Han, S., Zhuang, H., Arja, R. D. & Reeves, W. H. A novel monocyte differentiation pattern in pristane-induced lupus with diffuse alveolar hemorrhage. Elife 11, e76205(2022).
Nedeva, C. et al. TREML4 receptor regulates inflammation and innate immune cell death during polymicrobial sepsis. Nat. Immunol. 21, 1585–1596 (2020).
Bosma, M. et al. FNDC4 acts as an anti-inflammatory factor on macrophages and improves colitis in mice. Nat. Commun. 7, 11314 (2016).
Lv, Z. T. et al. FNDC4 inhibits RANKL-induced osteoclast formation by suppressing NF-κB activation and CXCL10 expression. Biomed. Res. Int. 2018, 3936257 (2018).
Wang, Z. et al. Fibronectin type III domain-containing 4 promotes the migration and differentiation of bovine skeletal muscle-derived satellite cells via focal adhesion kinase. Cell Adh. Migr. 14, 153–164 (2020).
Park, D. D. et al. Resident and elicited murine macrophages differ in expression of their glycomes and glycan-binding proteins. Cell Chem. Biol. 28, 567–582.e564 (2021).
Nguyen, T. H., Abidin, B. M. & Heinonen, K. M. Frizzled-6 promotes hematopoietic stem/progenitor cell mobilization and survival during LPS-induced emergency myelopoiesis. Stem Cell Rep. 17, 2303–2317 (2022).
Liu, S. et al. Loss of EMP1 promotes the metastasis of human bladder cancer cells by promoting migration and conferring resistance to ferroptosis through activation of PPAR gamma signaling. Free Radic. Biol. Med. 189, 42–57 (2022).
Caratti, G. et al. Glucocorticoid activation of anti-inflammatory macrophages protects against insulin resistance. Nat. Commun. 14, 2271 (2023).
Lindhorst, A. et al. Adipocyte death triggers a pro-inflammatory response and induces metabolic activation of resident macrophages. Cell Death Dis. 12, 579 (2021).
Fink, L. N. et al. Expression of anti-inflammatory macrophage genes within skeletal muscle correlates with insulin sensitivity in human obesity and type 2 diabetes. Diabetologia 56, 1623–1628 (2013).
Bae, H. R. et al. Chronic expression of interferon-gamma leads to murine autoimmune cholangitis with a female predominance. Hepatology 64, 1189–1201 (2016).
Chan, P. C. et al. Targetted inhibition of CD74 attenuates adipose COX-2-MIF-mediated M1 macrophage polarization and retards obesity-related adipose tissue inflammation and insulin resistance. Clin. Sci. 132, 1581–1596 (2018).
Wang, Y. et al. Tissue-resident macrophages promote extracellular matrix homeostasis in the mammary gland stroma of nulliparous mice. Elife 9, e57438 (2020).
Adamson, S. E. et al. Disabled homolog 2 controls macrophage phenotypic polarization and adipose tissue inflammation. J. Clin. Invest. 126, 1311–1322 (2016).
Shaul, M. E., Bennett, G., Strissel, K. J., Greenberg, A. S. & Obin, M. S. Dynamic, M2-like remodeling phenotypes of CD11c+ adipose tissue macrophages during high-fat diet–induced obesity in mice. Diabetes 59, 1171–1181 (2010).
Wu, L. et al. C1QTNF1 attenuates angiotensin II-induced cardiac hypertrophy via activation of the AMPKa pathway. Free Radic. Biol. Med. 121, 215–230 (2018).
Jia, Y. et al. Circulating CTRP9 levels are increased in patients with newly diagnosed type 2 diabetes and correlated with insulin resistance. Diab. Res. Clin. Pract. 131, 116–123 (2017).
Wei, Z., Lei, X., Petersen, P. S., Aja, S. & Wong, G. W. Targeted deletion of C1q/TNF-related protein 9 increases food intake, decreases insulin sensitivity, and promotes hepatic steatosis in mice. Am. J. Physiol. Endocrinol. Metab. 306, E779–E790 (2014).
Wang, X. et al. Prolonged hypernutrition impairs TREM2-dependent efferocytosis to license chronic liver inflammation and NASH development. Immunity 56, 58–77.e11 (2023).
Li, Q. et al. Obesity and hyperinsulinemia drive adipocytes to activate a cell cycle program and senesce. Nat. Med. 27, 1941–1953 (2021).
Carvalho, E. et al. Low cellular IRS 1 gene and protein expression predict insulin resistance and NIDDM. FASEB J. 13, 2173–2178 (1999).
Withers, D. J. et al. Disruption of IRS-2 causes type 2 diabetes in mice. Nature 391, 900–904 (1998).
Laustsen, P. G. et al. Lipoatrophic diabetes in Irs1(-/-)/Irs3(-/-) double knockout mice. Genes Dev. 16, 3213–3222 (2002).
Gan, C. et al. Natural deletion of mouse carboxylesterases Ces1c/d/e impacts drug metabolism and metabolic syndrome development. Biomed. Pharmacother. 164, 114956 (2023).
Ouchi, N. et al. Sfrp5 is an anti-inflammatory adipokine that modulates metabolic dysfunction in obesity. Science 329, 454–457 (2010).
Li, S., Shin, H. J., Ding, E. L. & van Dam, R. M. Adiponectin levels and risk of type 2 diabetes: a systematic review and meta-analysis. JAMA 302, 179–188 (2009).
Vincent, V. et al. ATP-binding cassette transporter A1 (ABCA1) expression in adipose tissue and its modulation with insulin resistance in obesity. Diab. Metab. Syndr. Obes. 12, 275–284 (2019).
de Haan, W., Bhattacharjee, A., Ruddle, P., Kang, M. H. & Hayden, M. R. ABCA1 in adipocytes regulates adipose tissue lipid content, glucose tolerance, and insulin sensitivity. J. Lipid Res. 55, 516–523 (2014).
Son, D., Na, Y. R., Hwang, E. S. & Seok, S. H. Platelet-derived growth factor-C (PDGF-C) induces anti-apoptotic effects on macrophages through Akt and Bad phosphorylation. J. Biol. Chem. 289, 6225–6235 (2014).
Nei, Y. et al. GATA-1 regulates the generation and function of basophils. Proc. Natl. Acad. Sci. USA 110, 18620–18625 (2013).
Tanaka, H. et al. GATA-1 blocks IL-6-induced macrophage differentiation and apoptosis through the sustained expression of cyclin D1 and bcl-2 in a murine myeloid cell line M1. Blood 95, 1264–1273 (2000).
Gautier, E. L. et al. Gata6 regulates aspartoacylase expression in resident peritoneal macrophages and controls their survival. J. Exp. Med. 211, 1525–1531 (2014).
Annevelink, C. E., Sapp, P. A., Petersen, K. S., Shearer, G. C. & Kris-Etherton, P. M. Diet-derived and diet-related endogenously produced palmitic acid: effects on metabolic regulation and cardiovascular disease risk. J. Clin. Lipidol. 17, 577–586 (2023).
Qiu, T. et al. Obesity-induced elevated palmitic acid promotes inflammation and glucose metabolism disorders through GPRs/NF-kappaB/KLF7 pathway. Nutr. Diab. 12, 23 (2022).
Hotamisligil, G. S., Arner, P., Caro, J. F., Atkinson, R. L. & Spiegelman, B. M. Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance. J. Clin. Invest. 95, 2409–2415 (1995).
Hotamisligil, G. S., Shargill, N. S. & Spiegelman, B. M. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 259, 87–91 (1993).
Rocha, V. Z. et al. Interferon-gamma, a Th1 cytokine, regulates fat inflammation: a role for adaptive immunity in obesity. Circ. Res. 103, 467–476 (2008).
Kronke, J. et al. Lenalidomide causes selective degradation of IKZF1 and IKZF3 in multiple myeloma cells. Science 343, 301–305 (2014).
Cai, J., Yang, J. & Jones, D. P. Mitochondrial control of apoptosis: the role of cytochrome c. Biochim. Biophys. Acta 1366, 139–149 (1998).
Garrido, C. et al. Mechanisms of cytochrome c release from mitochondria. Cell Death Differ. 13, 1423–1433 (2006).
Sadaf, S. et al. Pyroptotic and apoptotic cell death in iNOS and nNOS overexpressing K562 cells: a mechanistic insight. Biochem. Pharm. 176, 113779 (2020).
Ribas, V., García-Ruiz, C. & Fernández-Checa, J. C. Glutathione and mitochondria. Front. Pharm. 5, 151 (2014).
Diaz, F., Thomas, C. K., Garcia, S., Hernandez, D. & Moraes, C. T. Mice lacking COX10 in skeletal muscle recapitulate the phenotype of progressive mitochondrial myopathies associated with cytochrome c oxidase deficiency. Hum. Mol. Genet. 14, 2737–2748 (2005).
Baek, J. H. et al. Deletion of the mitochondrial complex-IV cofactor heme a:farnesyltransferase causes focal segmental glomerulosclerosis and interferon response. Am. J. Pathol. 188, 2745–2762 (2018).
Murlanova, K. et al. Deficient mitochondrial respiration in astrocytes impairs trace fear conditioning and increases naloxone-precipitated aversion in morphine-dependent mice. Glia 70, 1289–1300 (2022).
Ahola, S. et al. OMA1-mediated integrated stress response protects against ferroptosis in mitochondrial cardiomyopathy. Cell Metab. 34, 1875–1891.e1877 (2022).
Schiffmann, L. M. et al. Mitochondrial respiration controls neoangiogenesis during wound healing and tumour growth. Nat. Commun. 11, 3653 (2020).
Hofwimmer, K. et al. IL-1beta promotes adipogenesis by directly targeting adipocyte precursors. Nat. Commun. 15, 7957 (2024).
Choy, L. & Derynck, R. Transforming growth factor-beta inhibits adipocyte differentiation by Smad3 interacting with CCAAT/enhancer-binding protein (C/EBP) and repressing C/EBP transactivation function. J. Biol. Chem. 278, 9609–9619 (2003).
Spiegelman, B. M. & Farmer, S. R. Decreases in tubulin and actin gene expression prior to morphological differentiation of 3T3 adipocytes. Cell 29, 53–60 (1982).
Teichert-Kuliszewska, K. et al. Increasing vimentin expression associated with differentiation of human and rat preadipocytes. Int. J. Obes. Relat. Metab. Disord. 20, S108–S113 (1996).
Kim, S., Kim, I., Cho, W., Oh, G. T. & Park, Y. M. Vimentin deficiency prevents high-fat diet-induced obesity and insulin resistance in mice. Diab. Metab. J. 45, 97–108 (2021).
Bajpai, G. et al. The human heart contains distinct macrophage subsets with divergent origins and functions. Nat. Med. 24, 1234–1245 (2018).
Dick, S. A. et al. Self-renewing resident cardiac macrophages limit adverse remodeling following myocardial infarction. Nat. Immunol. 20, 29–39 (2019).
Epelman, S. et al. Embryonic and adult-derived resident cardiac macrophages are maintained through distinct mechanisms at steady state and during inflammation. Immunity 40, 91–104 (2014).
Lavine, K. J. et al. Distinct macrophage lineages contribute to disparate patterns of cardiac recovery and remodeling in the neonatal and adult heart. Proc. Natl. Acad. Sci. USA 111, 16029–16034 (2014).
Mass, E. et al. Specification of tissue-resident macrophages during organogenesis. Science 353, aaf4238 (2016).
Williams, J. W. et al. Limited proliferation capacity of aortic intima resident macrophages requires monocyte recruitment for atherosclerotic plaque progression. Nat. Immunol. 21, 1194–1204 (2020).
Chuang, S. Y. et al. TLR-induced PAI-2 expression suppresses IL-1beta processing via increasing autophagy and NLRP3 degradation. Proc. Natl. Acad. Sci. USA 110, 16079–16084 (2013).
Delhase, M. et al. TANK-binding kinase 1 (TBK1) controls cell survival through PAI-2/serpinB2 and transglutaminase 2. Proc. Natl. Acad. Sci. USA 109, E177–E186 (2012).
Dickinson, J. L., Bates, E. J., Ferrante, A. & Antalis, T. M. Plasminogen activator inhibitor type 2 inhibits tumor necrosis factor alpha-induced apoptosis. Evidence for an alternate biological function. J. Biol. Chem. 270, 27894–27904 (1995).
Kasyapa, C. S., Kunapuli, P., Hawthorn, L. & Cowell, J. K. Induction of the plasminogen activator inhibitor-2 in cells expressing the ZNF198/FGFR1 fusion kinase that is involved in atypical myeloproliferative disease. Blood 107, 3693–3699 (2006).
Kumar, S. & Baglioni, C. Protection from tumor necrosis factor-mediated cytolysis by overexpression of plasminogen activator inhibitor type-2. J. Biol. Chem. 266, 20960–20964 (1991).
Medcalf, R. L. & Stasinopoulos, S. J. The undecided serpin. The ins and outs of plasminogen activator inhibitor type 2. FEBS J. 272, 4858–4867 (2005).
Park, J. M. et al. Signaling pathways and genes that inhibit pathogen-induced macrophage apoptosis–CREB and NF-kappaB as key regulators. Immunity 23, 319–329 (2005).
Schroder, W. A. et al. A physiological function of inflammation-associated SerpinB2 is regulation of adaptive immunity. J. Immunol. 184, 2663–2670 (2010).
Tonnetti, L. et al. SerpinB2 protection of retinoblastoma protein from calpain enhances tumor cell survival. Cancer Res. 68, 5648–5657 (2008).
Zhao, A. et al. SerpinB2 is critical to Th2 immunity against enteric nematode infection. J. Immunol. 190, 5779–5787 (2013).
Kim, H. H. et al. xCT-mediated glutamate excretion in white adipocytes stimulates interferon-gamma production by natural killer cells in obesity. Cell Rep. 42, 112636 (2023).
Yao, J. et al. Macrophage IRX3 promotes diet-induced obesity and metabolic inflammation. Nat. Immunol. 22, 1268–1279 (2021).
Lawler, H. M. et al. Adipose tissue hypoxia, inflammation, and fibrosis in obese insulin-sensitive and obese insulin-resistant subjects. J. Clin. Endocrinol. Metab. 101, 1422–1428 (2016).
Franco, R. & Cidlowski, J. A. Glutathione efflux and cell death. Antioxid. Redox Signal. 17, 1694–1713 (2012).
D’Alessio, M. et al. Glutathione depletion up-regulates Bcl-2 in BSO-resistant cells. FASEB J. 18, 1609–1611 (2004).
Ow, Y. P., Green, D. R., Hao, Z. & Mak, T. W. Cytochrome c: functions beyond respiration. Nat. Rev. Mol. Cell Biol. 9, 532–542 (2008).
Deneke, S. M., Steiger, V. & Fanburg, B. L. Effect of hyperoxia on glutathione levels and glutamic acid uptake in endothelial cells. J. Appl. Physiol. 63, 1966–1971 (1987).
Lash, L. H. Mitochondrial glutathione transport: physiological, pathological and toxicological implications. Chem. Biol. Interact. 163, 54–67 (2006).
Boutens, L. et al. Unique metabolic activation of adipose tissue macrophages in obesity promotes inflammatory responses. Diabetologia 61, 942–953 (2018).
Serbulea, V. et al. Macrophage phenotype and bioenergetics are controlled by oxidized phospholipids identified in lean and obese adipose tissue. Proc. Natl. Acad. Sci. USA 115, E6254–E6263 (2018).
Wculek, S. K. et al. Oxidative phosphorylation selectively orchestrates tissue macrophage homeostasis. Immunity 56, 516–530.e519 (2023).
Campbell, C. T., Kolesar, J. E. & Kaufman, B. A. Mitochondrial transcription factor A regulates mitochondrial transcription initiation, DNA packaging, and genome copy number. Biochim. Biophys. Acta 1819, 921–929 (2012).
Gao, X. et al. TFAM-sdependent mitochondrial metabolism is required for alveolar macrophage maintenance and homeostasis. J. Immunol. 208, 1456–1466 (2022).
Stenkula, K. G. & Erlanson-Albertsson, C. Adipose cell size: importance in health and disease. Am. J. Physiol. Regul. Integr. Comp. Physiol. 315, R284–R295 (2018).
Strissel, K. J. et al. Adipocyte death, adipose tissue remodeling, and obesity complications. Diabetes 56, 2910–2918 (2007).
Shimobayashi, M. et al. Insulin resistance causes inflammation in adipose tissue. J. Clin. Invest. 128, 1538–1550 (2018).
Cox, N. et al. Diet-regulated production of PDGFcc by macrophages controls energy storage. Science 373, eabe9383 (2021).
Chang, Y. H., Ho, K. T., Lu, S. H., Huang, C. N. & Shiau, M. Y. Regulation of glucose/lipid metabolism and insulin sensitivity by interleukin-4. Int. J. Obes. 36, 993–998 (2012).
Vasamsetti, S. B. et al. Sympathetic neuronal activation triggers myeloid progenitor proliferation and differentiation. Immunity 49, 93–106.e107 (2018).
Kim, J. R. et al. Association of anti-obesity activity of N-acetylcysteine with metallothionein-II down-regulation. Exp. Mol. Med. 38, 162–172 (2006).
Tsao, C. H., Shiau, M. Y., Chuang, P. H., Chang, Y. H. & Hwang, J. Interleukin-4 regulates lipid metabolism by inhibiting adipogenesis and promoting lipolysis. J. Lipid Res. 55, 385–397 (2014).
Ayala, J. E. et al. Standard operating procedures for describing and performing metabolic tests of glucose homeostasis in mice. Dis. Model. Mech. 3, 525–534 (2010).
Coppin, E. et al. Peripheral ischemia imprints epigenetic changes in hematopoietic stem cells to propagate inflammation and atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 43, 889–906 (2023).